FEBS Letters · 2012 · 42 citations · 20 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyEpigeneticsEnzyme InhibitionEnzyme ScreeningOncology PharmacologyStructure-activity Relationship AnalysisAssayHistone Demethylase InhibitionHistone DemethylasesHistone DemethylationHistone-lysine AcetylationInhibitor ScreeningLysine Methyltransferase ActivityNatural Product Library Screening
Identification of inhibitors of histone-lysine demethylase (HDM) enzymes is important because of their involvement in the development of cancer. An ELISA-based assay was developed for identification of inhibitors of the HDM KDM4C in a natural products library. Based on one of the hits with affinity in the low μM range (1, a catechol), a subset of structurally related compounds was selected and tested against a panel of HDMs. In this subset, two inhibitors (2 and 10) had comparable affinities towards KDM4C and KDM6A but no effect on PHF8. One inhibitor restored H3K9me3 levels in KDM4C transfected U2-OS cells.
20
Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
Johnathan R. Whetstine, Amanda C. Nottke, Fei Lan et al. · Cell · 2006 · 1K citations · Full text
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Paul A. Cloos, Karl Agger, Alessio Maiolica et al. · Nature · 2006 · 749 citations
Tae‐Wook Chung, Sung‐Kwon Moon, Young‐Chae Chang et al. · The FASEB Journal · 2004 · 457 citations
Medicine, Oncology, Pharmacology +15